Studies on Competition and Antitrust Issues in the Pharmaceutical Industry
Aus der Reihe
BestMasters
-
- Taschenbuch ausgewählt
- eBook
-
Sprache:Englisch
Fr. 120.00
inkl. gesetzl. MwSt.,
Beschreibung
Produktdetails
Einband
Taschenbuch
Erscheinungsdatum
22.11.2016
Abbildungen
XIV, 3 illus., schwarz-weiss Illustrationen
Verlag
Springer Fachmedien Wiesbaden GmbHSeitenzahl
85
Maße (L/B/H)
21.1/14.9/1.2 cm
Gewicht
142 g
Sprache
Englisch
ISBN
978-3-658-16550-5
This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example, pay-for-delay strategies, market foreclosure, resale price maintenance, but also mergers and acquisitions, while taking into account market specificities such as the unique research and development process. The study explains why drug prices sometimes remain at elevated levels even after the drug’s patent protection has expired. Knowing the characteristics of such anticompetitive strategies helps customers such as health insurance companies to develop effective counter-strategies.
Kundinnen und Kunden meinen
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kund*innen durch Ihre Meinung